Evidence map›Paper›PMID 31148993›Full record

ArticleAfrican health sciences2019

The perceived barriers to insulin therapy among type 2 diabetic patients.

Amin Hussein, Arafa Mostafa, Alnomi Areej, Al-Muteb Mona, Alduaiji Shimaa, Al-Gazlan Najd, Alnemari Futoon

Abstract read
In one paragraph

Article in African health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Barriers and facilitators to insulin treatment: a phenomenological inquiry.Journal of pharmaceutical policy and practice · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amin HusseinKing Saud University, Family and Community Medicine.
Arafa MostafaKing Saud University, Chair of Cancer Research.
Alnomi AreejKing Saud University, Family and Community Medicine.
Al-Muteb MonaKing Saud University, Family and Community Medicine.
Alduaiji ShimaaKing Saud University, Family and Community Medicine.
Al-Gazlan NajdKing Saud University, Family and Community Medicine.
Alnemari FutoonKing Saud University, Family and Community Medicine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProblems may arise with insulin treatment, due to patients' perspective towards it leading to refusal.

objectivesTo evaluate diabetic patients' refusal towards insulin therapy, and to assess patients' perception and perceived barriers towards insulin.

methodsA cross-sectionalstudy, where type 2 diabetics participated in the study during a period, February through March 2017. They were interviewed in person by a questionnaire including three sections; socio-demography, medical history and a health belief model, comprising barriers to use insulin. Five points Likert scale was used to measure patients' perception and barriers towards insulin therapy.

resultsOne fourth (24.4%) of the diabetic patients refused insulin. Among the controlled group, 34.4% refused insulin, while 21% refused insulin among the uncontrolled group. The study showed different barriers towards insulin therapy, including fear of injection, pain, insulin injection needs help from others, fear of hypoglycaemia and embarrassment.

conclusionDiabetics showed a negative attitude towards insulin therapy due to social and psychological factors. The results necessitate the development of a strategy to address problems related with a reluctance to initiate insulin and put a strategy to implement education and better interaction with diabetic team to the stigma from phobia from insulin use.

Indexed as

Social StigmaAdultAgedAmbulatory Care FacilitiesCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsInsulinMaleMiddle AgedPatient Acceptance of Health CareSaudi ArabiaSelf CareSurveys and QuestionnairesHypoglycemic AgentsInsulinBarriers to insulin therapytype 2 diabetic patients

Identifiers

PMID31148993
PMCPMC6531943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.